Home › Trial NCT03892993
Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
- Trial IDNCT03892993
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorM.D. Anderson Cancer Center
- Enrollment120
- Start date2019-04-09
- ConditionsThyroid Gland Medullary Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.